Synovial membrane-derived mesenchymal progenitor cells from osteoarthritic joints in dogs possess lower chondrogenic-, and higher osteogenic capacity compared to normal joints

BACKGROUND: Synovial membrane-derived mesenchymal progenitor cells (SM-MPCs) are a promising candidate for the cell-based treatment of osteoarthritis (OA) considering their in vitro and in vivo capacity for cartilage repair. However, the OA environment may adversely impact their regenerative capacit...

Descripción completa

Detalles Bibliográficos
Autores principales: Teunissen, M., Ahrens, N. S., Snel, L., Narcisi, R., Kamali, S. A., van Osch, G. J. V. M., Meij, B. P., Mastbergen, S. C., Sivasubramaniyan, K., Tryfonidou, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446738/
https://www.ncbi.nlm.nih.gov/pubmed/36064441
http://dx.doi.org/10.1186/s13287-022-03144-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446738/
https://www.ncbi.nlm.nih.gov/pubmed/36064441
http://dx.doi.org/10.1186/s13287-022-03144-z

Ejemplares similares